| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,874 |
2,836 |
$216K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,771 |
3,653 |
$204K |
| 99215 |
Prolong outpt/office vis |
1,900 |
1,266 |
$129K |
| 11043 |
|
1,744 |
623 |
$64K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,629 |
1,139 |
$26K |
| 99443 |
|
495 |
404 |
$23K |
| 93000 |
|
1,075 |
914 |
$12K |
| 82962 |
|
2,141 |
1,852 |
$3K |
| 99442 |
|
72 |
58 |
$3K |
| 99205 |
Prolong outpt/office vis |
53 |
29 |
$2K |
| 11045 |
|
58 |
30 |
$544.88 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
38 |
26 |
$143.10 |
| 94760 |
|
70 |
68 |
$96.28 |
| 90686 |
|
13 |
13 |
$43.04 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
65 |
49 |
$23.06 |
| 90658 |
|
97 |
44 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
134 |
88 |
$0.00 |
| Q2036 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) |
21 |
20 |
$0.00 |